نتائج البحث

Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects (INSIGHT)

• Source: Akerley WL, Arnaud AM, Reddy B, Page RD. Impact of a multivariate serum-based proteomic test on physician treatment recommendations for advanced non-small-cell lung cancer. Curr Med Res Opin. 2017

تفاصيل العنوان

Molecular and translational biology of the blood-based VeriStrat® proteomic test used in cancer immunotherapy treatment guidance

• Authors : Matthew A. Koc; Timothy Aaron Wiles; Daniel C. Weinhold

Subjects: Prognostic; Mass spectrometry; Top-down proteomics

• Source: Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 30, Iss , Pp 51-60 (2023)

تفاصيل العنوان

Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®. (EMPHASIS)

• Authors : Biodesix, Inc.

• Source: Di Maio M, Chiodini P, Georgoulias V, Hatzidaki D, Takeda K, Wachters FM, Gebbia V, Smit EF, Morabito A, Gallo C, Perrone F, Gridelli C. Meta-analysis of single-agent chemotherapy compared with

تفاصيل العنوان

The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

• Authors : Mary Jo Fidler; Cristina L. Fhied; Joanna Roder

Subjects: Biomarker; Serum; Non-small cell lung cancer (NSCLC)

• Source: BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)

تفاصيل العنوان

Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patients.

• Authors : Jia, Bo¹ (AUTHOR); Dong, Zhi² (AUTHOR); Wu, Di³ (AUTHOR)

• Source: Cancer Cell International. 12/9/2020, Vol. 20 Issue 1, p1-7. 7p.

تفاصيل العنوان

Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy

• Authors : Francesco Grossi, MD

• Source: An Exploratory Study of the Performance of Mass-Spectrometry Based Test Veristrat in Prediction of Benefit of First Line NSCLC Patients From Treatment With Standard

تفاصيل العنوان

Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patients

• Authors : Chen Chen; Minglei Zhuo; Di Wu

Subjects: Oncology; Lung adenocarcinoma; Cancer Research

• Source: Cancer Cell International, Vol 20, Iss 1, Pp 1-7 (2020)Cancer Cell International

تفاصيل العنوان

Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patients

• Authors : Bo Jia; Zhi Dong; Di Wu

Subjects: Lung adenocarcinoma; Pemetrexed; Prognosis

• Source: Cancer Cell International, Vol 20, Iss 1, Pp 1-7 (2020)

تفاصيل العنوان

Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial

Subjects: Cancérologie; Pneumologie; Docetaxel

• Source: Journal of Thoracic Oncology, 12 (4

تفاصيل العنوان

A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation

• Source: A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation

تفاصيل العنوان